Discover how a single daily pill is transforming hypertension treatment. Simplified care and better results are reshaping patient health globally.

Progestin-only contraceptives, such as the mini-pill, hormonal IUDs, and implants, are generally considered safer for heart health than combination pills.

The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.

WIDAPLIK™, a newly FDA-approved triple combo pill, promises better blood pressure control for adults, including those starting hypertension treatment for the first time.

A revolutionary new blood pressure pill is being trialled which could dramatically transform the lives of people living with hypertension. GMRx2 is a ‘3-in-1’ drug which combines doses of ...

Mini pill linked to ‘elevated’ asthma attack risk among certain women The study’s findings highlight a potential risk factor for younger women with asthma considering their contraceptive options ...

Millions of women using a common contraceptive pill could be at greater risk of developing a brain tumour, new research suggests. The mini-pill—a daily birth control tablet that contains the ...

Could a single-pill combination of amlodipine/atorvastatin effectively reduce blood pressure and lipid levels and could it really help patients achieve goals for both comorbidities?

For Black African adults with uncontrolled hypertension, a low-dose triple-pill protocol achieves better blood pressure than standard care.

Phase III trial results of novel triple combination pill for hypertension published in The Lancet Novel combination pill significantly reduced blood pressure and improved control rates vs dual ...

Reductions seen in mean office sitting systolic BP and sitting diastolic BP and in mean 24-hour ambulatory systolic BP. (HealthDay News) — For patients with resistant hypertension, a quadruple ...

Systolic blood pressure was 31 points lower in the combo pill group after six months of treatment, compared to 26 points lower with standard care, results showed.